Force Pharma Capital, 265 State Route 34 Lower Level, Colts Neck, NJ (2026)

08/01/2020

Most Recent Changes to the Inactive Ingredient Database — Read on www.fda.gov/drugs/drug-approvals-and-databases/most-recent-changes-iid-database
http://forcepharmacapital.com/most-recent-changes-to-the-iid-database-fda-2/

Most Recent Changes to the Inactive Ingredient Database — Read on www.fda.gov/drugs/drug-approvals-and-databases/most-recent-changes-iid-database

02/02/2020

Some REMS programs may only require a medication guide to be distributed with each dispense that highlight safety information, such as relevant adverse events and risks associated with taking the product. — Read on www.pharmacytimes.com/ Great article to help understand the impact of adverse events reporting and how it is beneficial to public health to have programs like these.
http://forcepharmacapital.com/the-history-benefits-of-pharmaceutical-rems-programs/

Some REMS programs may only require a medication guide to be distributed with each dispense that highlight safety information, such as relevant adverse events and risks associated with taking the p…

02/01/2020

FDA approves first drug for treatment of peanut allergy for children — Read on s2027422842.t.en25.com/e/es This is a huge achievement for all food allergy companies. Looking forward to this rise of this market.
http://forcepharmacapital.com/fda-approves-first-drug-for-treatment-of-peanut-allergy-for-children/

FDA approves first drug for treatment of peanut allergy for children — Read on s2027422842.t.en25.com/e/es This is a huge achievement for all food allergy companies. Looking forward to this rise of…

01/24/2020

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer — Read on s2027422842.t.en25.com/e/es
http://forcepharmacapital.com/fda-approves-first-treatment-option-specifically-for-patients-with-epithelioid-sarcoma-a-rare-soft-tissue-cancer/

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer — Read on s2027422842.t.en25.com/e/es

01/11/2020

Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for patients. “First generics” are just what they sound like—the first approval by FDA which permits a manufacturer to market a generic drug product in the United States. — Read on www.fda.gov/drugs/drug-and-biologic-approval-and-ind-activity-reports/first-generic-drug-approvals
http://forcepharmacapital.com/first-generic-drug-approvals-fda-2/

Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-q…

12/13/2019

FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry — Read on s2027422842.t.en25.com/e/es Don't necessary agree with this approach.....
http://forcepharmacapital.com/fda-in-brief-new-analysis-highlights-link-between-generic-drug-competition-and-lower-drug-prices-underscores-importance-of-fda-efforts-to-spur-generic-drug-development-and-market-entry/

FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry — Read on …

12/13/2019

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update — Read on s2027422842.t.en25.com/e/es
http://forcepharmacapital.com/fda-grants-accelerated-approval-to-first-targeted-treatment-for-rare-duchenne-muscular-dystrophy-dmd-mutation-drug-information-update/

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update — Read on s2027422842.t.en25.com/e/es

12/13/2019

FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es
http://forcepharmacapital.com/fda-updates-list-of-off-patent-off-exclusivity-drugs-without-an-approved-generic/

FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es

12/11/2019

This press release highlights new NCCIH research awards totaling approximately $3 million to investigate the potential pain-relieving properties and mechanisms of actions of phytochemicals in cannabis. — Read on nccih.nih.gov/news/press/09192019
http://forcepharmacapital.com/nih-to-investigate-minor-cannabinoids-and-terpenes-for-potential-pain-relieving-properties-nccih/

This press release highlights new NCCIH research awards totaling approximately $3 million to investigate the potential pain-relieving properties and mechanisms of actions of phytochemicals in canna…

12/03/2019

A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. — Read on www.nih.gov/news-events/nih-research-matters/targeting-gut-bacteria-treat-alcoholic-hepatitis
http://forcepharmacapital.com/targeting-gut-bacteria-to-treat-alcoholic-hepatitis-national-institutes-of-health-nih/

A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. — Read on www.nih.gov/news-events/nih-research-matters/targeting-gut-bacteria-tre…

Force Pharma Capital

08/01/2020

02/02/2020

02/01/2020

01/24/2020

01/11/2020

12/13/2019

12/13/2019

12/13/2019

12/11/2019

12/03/2019

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share

Category